| Dr Steven L Rovenstine, DO | |
|
800 Raven Hill Drive, Atchison, KS 66002 | |
| (913) 367-2131 | |
| (913) 674-2023 |
| Full Name | Dr Steven L Rovenstine |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 800 Raven Hill Drive, Atchison, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396719035 | NPI | - | NPPES |
| 200261310B | Medicaid | KS |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atchison Hospital | Atchison, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amberwell Atchison Association | 2466363858 | 46 |
News Archive
Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.
The trade associations of the dietary supplement industry today reaffirmed the industry's support for the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements.
Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O'Neill, Scottish Secretary of the British Medical Association (BMA), said:
An EU-funded project is developing a super-resolution microscope small enough to fit on to a computer chip that can be used to see changes in living cells in real time.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
› Verified 5 days ago
| Entity Name | Amberwell Atchison Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932151487 PECOS PAC ID: 2466363858 Enrollment ID: O20040329001560 |
News Archive
Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.
The trade associations of the dietary supplement industry today reaffirmed the industry's support for the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements.
Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O'Neill, Scottish Secretary of the British Medical Association (BMA), said:
An EU-funded project is developing a super-resolution microscope small enough to fit on to a computer chip that can be used to see changes in living cells in real time.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
› Verified 5 days ago
| Entity Name | Pittsburg Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043493240 PECOS PAC ID: 4587733886 Enrollment ID: O20080513000115 |
News Archive
Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.
The trade associations of the dietary supplement industry today reaffirmed the industry's support for the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements.
Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O'Neill, Scottish Secretary of the British Medical Association (BMA), said:
An EU-funded project is developing a super-resolution microscope small enough to fit on to a computer chip that can be used to see changes in living cells in real time.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
› Verified 5 days ago
| Entity Name | Sound Physicians Emergency Medicine Of Kansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831689934 PECOS PAC ID: 6800141672 Enrollment ID: O20180619001843 |
News Archive
Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.
The trade associations of the dietary supplement industry today reaffirmed the industry's support for the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements.
Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O'Neill, Scottish Secretary of the British Medical Association (BMA), said:
An EU-funded project is developing a super-resolution microscope small enough to fit on to a computer chip that can be used to see changes in living cells in real time.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven L Rovenstine, DO 800 Raven Hill Drive, Atchison, KS 66002 Ph: (913) 367-2131 | Dr Steven L Rovenstine, DO 800 Raven Hill Drive, Atchison, KS 66002 Ph: (913) 367-2131 |
News Archive
Valocor Therapeutics, Inc., a newly formed company focused on the development of innovative therapies for the treatment of dermatologic conditions, today announced the acquisition and license of certain dermatology therapeutic programs from QLT Inc.. This transaction was facilitated by a seed financing for Valocor led by the Working Opportunity Fund, which is managed by GrowthWorks Capital Ltd.
The trade associations of the dietary supplement industry today reaffirmed the industry's support for the responsible sale and use of health-promoting vitamins, minerals, herbs and other dietary supplements.
Commenting on the judgement announced by the Right Hon. Lord Nimmo Smith on the case of Mrs Margaret McTear against Imperial Tobacco Limited today (Tuesday 31 May 2005), Dr Bill O'Neill, Scottish Secretary of the British Medical Association (BMA), said:
An EU-funded project is developing a super-resolution microscope small enough to fit on to a computer chip that can be used to see changes in living cells in real time.
The Philadelphia Inquirer on Sunday examined the efficacy of Genomic Health's Oncotype DX test and Amsterdam, Netherlands-based Agendia's MammaPrint, both of which measure a woman's odds of breast cancer relapse by testing her removed tumor for genes that can predict the likelihood of her cancer returning.
› Verified 5 days ago
Randy Kellenberger, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Ravenhill Dr, Emergency Department, Atchison, KS 66002 Phone: 913-360-5320 | |
Dr. Justin Lee Theleman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Ravenhill Dr, Atchison, KS 66002 Phone: 913-367-2131 Fax: 913-674-2040 |